PaxMedica Rings the Nasdaq Stock Market Closing Bell
PaxMedica (Nasdaq: PXMD), a clinical-stage biopharmaceutical company focused on drug development for neurodevelopmental disorders such as autism, visits the Nasdaq MarketSite in Times Square. In honor of the occasion, Mr. Howard Weisman, CEO, rings the Closing Bell.